Health AI Central
Share:
Peer-Reviewed Publication
Adv Exp Med Biol2023;1396207-214.January 1, 2023Journal Article

Genomic Editing and Diabetes.

Parth Shah1
1ObvioHealth, New York, NY, USA. prshah06@gmail.com.
PubMed DOI

Abstract

The diabetes types and its complications have varying developmental and metabolic pathways. There is an interplay of nongenetic and genetic components in pathogenesis of diabetes and its complications. There are several established genes such as ABCC8, TCF7L2, SLC2A2, and CAPN10 which are known to influence blood insulin and glucose levels. Current management of diabetes types may include lifetime…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.